Skip to main content
Hyper Corporation Inc. logo

Hyper Corporation Inc. — Investor Relations & Filings

Ticker · 065650 ISIN · KR7065650004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 391 across all filing types
Latest filing 2024-04-08 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 065650

About Hyper Corporation Inc.

https://hyper-corp.com/

Hyper Corporation Inc. is a company transitioning from a clinical-stage biopharmaceutical firm to a new-tech-based platform provider. Its core Bio & Healthcare division develops treatments and diagnostic technologies for neurodegenerative diseases like Alzheimer's, aiming to build a comprehensive digital senior healthcare platform. The company is expanding by integrating AI and blockchain technologies into new sectors. Its IP & Content division focuses on securing intellectual property and innovating content distribution, while its New Tech division develops platforms to connect online and offline services. This strategy fuses its biotechnology expertise with advanced IT to create new business models and services.

Recent filings

Filing Released Lang Actions
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the exercise of conversion rights (convertible bonds) by Medifron. It details the number of shares to be issued, the conversion price, and an amendment to the listing date. This falls under capital structure changes and share issuance resulting from debt conversion, which is best classified as a Share Issue/Capital Change (SHA) filing.
2024-04-08 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). This type of regulatory filing details specific corporate transactions, including financial data, valuation reports, and counterparty information, which falls under the category of regulatory filings for material corporate events.
2024-04-05 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service and Korea Exchange regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). This type of regulatory filing in the Korean market is used to disclose significant corporate transactions, such as M&A or equity investments, to the public and regulators. Since it details a specific acquisition transaction and its financial implications, it falls under the category of M&A Activity (TAR).
2024-04-05 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). This type of regulatory filing is a mandatory disclosure for material corporate events, specifically M&A-related activities. Since it details the acquisition of shares in another entity, it falls under the M&A Activity category.
2024-04-05 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). It includes specific details about the transaction, such as the acquisition date, payment schedule, external valuation, and financial status of the target company. This type of regulatory filing for material corporate events is classified as a Regulatory Filing (RNS) within the provided schema, as it is a formal disclosure of a significant business transaction.
2024-04-05 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a 'Major Report' (주요사항보고서) concerning the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). This is a regulatory filing submitted to the Korea Exchange (KRX) and the Financial Services Commission (FSC) detailing corporate M&A activity and investment decisions. Since it is a formal regulatory disclosure of a material corporate event, it falls under the category of Regulatory Filings.
2024-04-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.